Apotex petitions SCOTUS for Cozaar/Hyzaar exclusivity review

The voice of Michael Corleone--"Just when I thought I was out...they pull me back in"--played over and over again in our heads today when we learned that Apotex filed a Petition for Writ of Certiorari with the U.S. Supreme Court asking for a review of the U.S. Court of Appeals for the District of Columbia Circuit's decision concerning 180-day exclusivity for generic versions of Merck's Cozaar and Hyzaar. Report